Palisade Bio (PALI) Cash from Investing Activities (QoQ) (2010 - 2020)
Palisade Bio (PALI) Cash from Investing Activities (QoQ) (2010 - 2020) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Palisade Bio |
391.02 Mn |
261.45 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2020 |
-200.00% |
| Mar 31, 2018 |
1,225,590.20% |
| Dec 31, 2017 |
-114.74% |
| Jun 30, 2016 |
-101.35% |
| Mar 31, 2016 |
393.27% |
| Dec 31, 2015 |
-125.56% |
| Sep 30, 2015 |
10,852.44% |
| Jun 30, 2015 |
5.45% |
| Mar 31, 2015 |
-29.24% |
| Dec 31, 2014 |
20.03% |
| Sep 30, 2014 |
43.91% |
| Jun 30, 2014 |
98.89% |
| Mar 31, 2014 |
-16,387.95% |
| Dec 31, 2013 |
55.42% |
| Sep 30, 2013 |
-47.11% |
| Jun 30, 2013 |
-45.42% |
| Mar 31, 2013 |
-45.50% |
| Dec 31, 2012 |
-72.27% |
| Sep 30, 2012 |
68.06% |
| Jun 30, 2012 |
-320.34% |
